Chickasaw Capital Management Lowered By $399,625 Its Johnson & Johnson (JNJ) Position; Kcm Investment Advisors Decreased Its Bristol (BMY) Stake

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Kcm Investment Advisors Llc decreased Bristol (BMY) stake by 3.38% reported in 2017Q4 SEC filing. Kcm Investment Advisors Llc sold 9,890 shares as Bristol (BMY)’s stock rose 2.38%. The Kcm Investment Advisors Llc holds 282,545 shares with $17.31M value, down from 292,435 last quarter. Bristol now has $88.42B valuation. The stock decreased 7.79% or $4.57 during the last trading session, reaching $54.08. About 34.84M shares traded or 363.08% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 17, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Chickasaw Capital Management Llc decreased Johnson & Johnson (JNJ) stake by 5.03% reported in 2017Q4 SEC filing. Chickasaw Capital Management Llc sold 2,875 shares as Johnson & Johnson (JNJ)’s stock declined 9.21%. The Chickasaw Capital Management Llc holds 54,251 shares with $7.58 million value, down from 57,126 last quarter. Johnson & Johnson now has $353.47B valuation. The stock increased 0.87% or $1.14 during the last trading session, reaching $131.76. About 6.38 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 17, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It improved, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. American Money Mngmt Limited Liability Com accumulated 30,156 shares or 2.55% of the stock. Nexus Inv Management Incorporated reported 10,026 shares. Dt Inv Prtn Ltd Liability stated it has 0.04% of its portfolio in Johnson & Johnson (NYSE:JNJ). Nippon Life Glob Invsts Americas holds 187,943 shares or 2.09% of its portfolio. Sva Plumb Wealth Lc invested in 1.62% or 98,860 shares. Moreover, S&Co has 3.68% invested in Johnson & Johnson (NYSE:JNJ) for 212,575 shares. Jfs Wealth Advsr Ltd Limited Liability Company has 24,504 shares. Moreover, Brandywine Global Investment Limited Com has 2.03% invested in Johnson & Johnson (NYSE:JNJ). Hedeker Wealth Ltd Liability Corporation owns 20,254 shares or 2.2% of their US portfolio. Berson And Corrado Limited Liability Corporation reported 0.27% of its portfolio in Johnson & Johnson (NYSE:JNJ). Paragon Capital Management accumulated 16,221 shares. Litman Gregory Asset Mgmt Ltd Limited Liability Company owns 1,636 shares for 0.07% of their portfolio. Bourgeon Capital Mngmt Ltd Liability Corp holds 6,178 shares. Archford Cap Strategies Lc owns 20,762 shares. Synovus Fincl reported 287,346 shares or 0.7% of all its holdings.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $136.72’s average target is 3.76% above currents $131.76 stock price. Johnson & Johnson had 95 analyst reports since August 7, 2015 according to SRatingsIntel. The company was downgraded on Monday, August 31 by Vetr. The rating was maintained by Credit Suisse with “Buy” on Thursday, October 19. The firm earned “Buy” rating on Sunday, August 27 by RBC Capital Markets. The rating was maintained by Cowen & Co on Tuesday, June 13 with “Buy”. The rating was maintained by Barclays Capital on Wednesday, April 20 with “Overweight”. The stock has “Buy” rating by Cowen & Co on Friday, October 6. The stock has “Neutral” rating by Citigroup on Tuesday, February 27. UBS maintained it with “Buy” rating and $14800 target in Wednesday, July 19 report. The rating was upgraded by Jefferies to “Buy” on Wednesday, October 11. Wells Fargo maintained the shares of JNJ in report on Friday, January 12 with “Buy” rating.

Chickasaw Capital Management Llc increased Enlink Midstream Partners Lp (NYSE:ENLK) stake by 42,569 shares to 6.06M valued at $93.15M in 2017Q4. It also upped Roche Holding Ltd Sp Adr (RHHBY) stake by 10,000 shares and now owns 40,000 shares. General Electric Co (NYSE:GE) was raised too.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity. Shares for $20.17M were sold by Stoffels Paulus.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 3 Sell and 11 Hold. Therefore 36% are positive. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. $64.18’s average target is 18.68% above currents $54.08 stock price. Bristol-Myers Squibb Company had 79 analyst reports since July 28, 2015 according to SRatingsIntel. The company was upgraded on Monday, August 24 by Piper Jaffray. Jefferies maintained the shares of BMY in report on Tuesday, June 14 with “Hold” rating. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Thursday, October 19 by Cowen & Co. Citigroup maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Friday, February 16. Citigroup has “Buy” rating and $78.0 target. The stock has “Hold” rating by Deutsche Bank on Monday, July 17. The rating was maintained by BMO Capital Markets on Friday, July 28 with “Underperform”. Berenberg downgraded the shares of BMY in report on Thursday, August 11 to “Hold” rating. BMO Capital Markets downgraded Bristol-Myers Squibb Company (NYSE:BMY) on Monday, January 25 to “Market Perform” rating. The company was maintained on Wednesday, October 18 by Citigroup. The firm has “Hold” rating by Cowen & Co given on Monday, August 14.

Since December 12, 2017, it had 1 insider buy, and 1 insider sale for $85,985 activity. $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) was bought by Samuels Theodore R. II. On Tuesday, December 12 the insider Lynch Thomas J. Jr. sold $335,172.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26 before the open. They expect $0.84 EPS, 0.00% or $0.00 from last year’s $0.84 per share. BMY’s profit will be $1.37 billion for 16.10 P/E if the $0.84 EPS becomes a reality. After $0.68 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 23.53% EPS growth.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It dived, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Maryland-based Burt Wealth has invested 0.24% in Bristol-Myers Squibb Company (NYSE:BMY). Rnc Mgmt Limited Co holds 3.61% or 851,156 shares in its portfolio. Pitcairn Com invested 0.1% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Cetera Ltd Llc reported 0.26% stake. Holderness reported 28,732 shares or 0.87% of all its holdings. Homrich & Berg has invested 0.04% in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Iowa Comml Bank has 1.49% invested in Bristol-Myers Squibb Company (NYSE:BMY). Alps Advisors has 0% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 8,629 shares. Tdam Usa holds 0.35% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 100,240 shares. Hudson Bay Capital Lp holds 50,000 shares or 0.07% of its portfolio. Waldron Limited Partnership holds 3,818 shares or 0.05% of its portfolio. Outfitter Advisors reported 7,132 shares stake. Highland Capital Mngmt Limited Liability Com holds 0.05% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 10,462 shares. Ims Mgmt invested in 0.77% or 20,178 shares. Obermeyer Wood Counsel Lllp reported 0.11% in Bristol-Myers Squibb Company (NYSE:BMY).

Kcm Investment Advisors Llc increased Bluerock Residential Growth 8. stake by 14,197 shares to 96,820 valued at $2.55M in 2017Q4. It also upped Allergan Plc (New) stake by 4,539 shares and now owns 38,335 shares. Home Depot Inc (NYSE:HD) was raised too.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart